A bipartisan group of lawmakers in the New Hampshire House of Representatives has announced plans to introduce a bill legalizing adult-use cannabis.
Majority leader of the House of Representatives, Jason Osborne, told NHPR, "The House has long united and worked together to find a way to get the job done for the people of Granite State. If we're lucky, the Senate will support the will of the vast majority of citizens of New Hampshire.
According to news media reports, although the legislation has not yet been officially introduced, it has already received support from the American Civil Liberties Union and the Americans for Prosperity.
According to NHPR, the proposal would allow adults aged 21 and older to possess or gift up to 4 ounces of marijuana and ultimately establish a licensed, commercial adult-use market with state-licensed dispensaries. The legislation would also include home-growing provisions, allowing adults aged 21 and older to cultivate up to six plants, including up to three mature plants.
According to a report by NHPR, the bill will also impose an 8.5% sales tax on retail marijuana sales, with the generated revenue going towards national pensions and drug abuse prevention programs. A portion of the income will also be designated for law enforcement agencies and municipal authorities with pharmacies.
The Democratic leader of the House, Matt Wilhelm, told NHPR that "legalizing the possession of small amounts of marijuana for adults is the right thing to do for New Hampshire, and we must accomplish it by 2023." He added that users of marijuana in the state's legal market "benefit from the testing and regulation of safer products.
Although the House of Representatives has repeatedly supported measures to legalize adult use of marijuana - most recently approving legislation in March allowing state-run liquor stores to sell marijuana - the Senate has thwarted these efforts.
Governor Chris Sununu may also impede efforts to reform the state's marijuana policies.
As previously reported by Cannabis Business Times, Sununu supports the decriminalization, removal, and medical marijuana plan in New Hampshire, but his voting record on patient access is mixed.
In 2019, Sununu vetoed a bill that would have ended the requirement for patients to establish a relationship with a supplier for at least three months before obtaining medical marijuana certification.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
